TY - JOUR AU - Rahman, N. AU - Stratton, M. R. PY - 1998 DA - 1998// TI - The genetics of breast cancer susceptibility. JO - Annu Rev Genet VL - 32 UR - https://doi.org/10.1146/annurev.genet.32.1.95 DO - 10.1146/annurev.genet.32.1.95 ID - Rahman1998 ER - TY - JOUR AU - Bertwistle, D. AU - Ashworth, A. PY - 1998 DA - 1998// TI - Functions of the BRCA1 and BRCA2genes. JO - Curr Opin Genet Dev VL - 8 UR - https://doi.org/10.1016/S0959-437X(98)80056-7 DO - 10.1016/S0959-437X(98)80056-7 ID - Bertwistle1998 ER - TY - JOUR AU - Easton, D. PY - 1997 DA - 1997// TI - Breast cancer genes: what are the real risks? JO - Nature Genet VL - 16 UR - https://doi.org/10.1038/ng0797-210 DO - 10.1038/ng0797-210 ID - Easton1997 ER - TY - JOUR AU - Miki, Y. AU - Swensen, J. AU - Shattuck-Eidens, D. PY - 1994 DA - 1994// TI - A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. JO - Science VL - 266 UR - https://doi.org/10.1126/science.7545954 DO - 10.1126/science.7545954 ID - Miki1994 ER - TY - JOUR AU - Wooster, R. AU - Bignell, G. AU - Lancaster, J. PY - 1995 DA - 1995// TI - Identification of the breast cancer susceptibility gene BRCA2. JO - Nature VL - 378 UR - https://doi.org/10.1038/378789a0 DO - 10.1038/378789a0 ID - Wooster1995 ER - TY - JOUR AU - Bork, P. AU - Blomberg, N. AU - Nilges, M. PY - 1996 DA - 1996// TI - Internal repeats in the BRCA2 protein sequence. JO - Nature Genet VL - 13 UR - https://doi.org/10.1038/ng0596-22 DO - 10.1038/ng0596-22 ID - Bork1996 ER - TY - JOUR AU - Bignell, G. AU - Micklem, G. AU - Stratton, M. R. AU - Ashworth, A. AU - Wooster, R. PY - 1997 DA - 1997// TI - The BRC repeats are conserved in mammalian BRCA2 proteins. JO - Hum Mol Genet VL - 6 UR - https://doi.org/10.1093/hmg/6.1.53 DO - 10.1093/hmg/6.1.53 ID - Bignell1997 ER - TY - JOUR AU - Chen, P. L. AU - Chen, C. F. AU - Chen, Y. PY - 1998 DA - 1998// TI - The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. JO - Proc Natl Acad Sci USA VL - 95 UR - https://doi.org/10.1073/pnas.95.9.5287 DO - 10.1073/pnas.95.9.5287 ID - Chen1998 ER - TY - JOUR AU - Wong, A. K. C. AU - Pero, R. AU - Ormonde, P. A. AU - Tavtigian, S. V. AU - Bartel, P. L. PY - 1997 DA - 1997// TI - RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene BRC. JO - J Biol Chem VL - 272 UR - https://doi.org/10.1074/jbc.272.51.31941 DO - 10.1074/jbc.272.51.31941 ID - Wong1997 ER - TY - STD TI - ,: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet. 1997, 349: 1505-1510. 10.1016/S0140-6736(96)10109-4. ID - ref10 ER - TY - JOUR AU - Chapman, M. S. AU - Verma, I. M. PY - 1996 DA - 1996// TI - Transcriptional activation by BRCA1. JO - Nature VL - 382 UR - https://doi.org/10.1038/382678a0 DO - 10.1038/382678a0 ID - Chapman1996 ER - TY - JOUR AU - Monteiro, A. N. A. AU - August, A. AU - Hanafusa, H. PY - 1996 DA - 1996// TI - Evidence for a transcriptional activation function of BRCA1 C-terminal region. JO - Proc Natl Acad Sci USA VL - 93 UR - https://doi.org/10.1073/pnas.93.24.13595 DO - 10.1073/pnas.93.24.13595 ID - Monteiro1996 ER - TY - JOUR AU - Haile, D. T. AU - Parvin, J. D. PY - 1999 DA - 1999// TI - Activation of transcription in vitro by the BRCA1 carboxyl-terminal domain. JO - J Biol Chem VL - 274 UR - https://doi.org/10.1074/jbc.274.4.2113 DO - 10.1074/jbc.274.4.2113 ID - Haile1999 ER - TY - JOUR AU - Scully, R. AU - Anderson, S. F. AU - Chao, D. M. PY - 1997 DA - 1997// TI - BRCA1 is a component of the RNA polymerase II holoenzyme. JO - Proc Natl Acad Sci USA VL - 94 UR - https://doi.org/10.1073/pnas.94.11.5605 DO - 10.1073/pnas.94.11.5605 ID - Scully1997 ER - TY - JOUR AU - Anderson, S. F. AU - Schlegel, B. P. AU - Nakajima, T. AU - Wolpin, E. S. AU - Parvin, J. D. PY - 1998 DA - 1998// TI - BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. JO - Nature Genet VL - 19 UR - https://doi.org/10.1038/930 DO - 10.1038/930 ID - Anderson1998 ER - TY - JOUR AU - Neish, A. S. AU - Anderson, S. F. AU - Schlegel, B. P. AU - Wei, W. AU - Parvin, J. D. PY - 1998 DA - 1998// TI - Factors associated with the mammalian RNA polymerase II holoenzyme. JO - Nucleic Acids Res VL - 26 UR - https://doi.org/10.1093/nar/26.3.847 DO - 10.1093/nar/26.3.847 ID - Neish1998 ER - TY - JOUR AU - Maldonado, E. AU - Shiekhattar, R. AU - Sheldon, M. PY - 1996 DA - 1996// TI - A human RNA polymerase II complex associated with SRB and DNA-repair proteins. JO - Nature VL - 381 UR - https://doi.org/10.1038/381086a0 DO - 10.1038/381086a0 ID - Maldonado1996 ER - TY - JOUR AU - Niculescu, A. B. AU - Chen, X. AU - Smeets, M. PY - 1998 DA - 1998// TI - Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. JO - Mol Cell Biol VL - 18 UR - https://doi.org/10.1128/MCB.18.1.629 DO - 10.1128/MCB.18.1.629 ID - Niculescu1998 ER - TY - JOUR AU - Somasundaram, K. AU - Zhang, H. AU - Zeng, Y. X. PY - 1997 DA - 1997// TI - Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1. JO - Nature VL - 389 UR - https://doi.org/10.1038/38291 DO - 10.1038/38291 ID - Somasundaram1997 ER - TY - JOUR AU - Zhang, H. AU - Somasundaram, K. AU - Peng, Y. PY - 1998 DA - 1998// TI - BRCA1 physically associates with p53 and stimulates its transcriptional activity. JO - Oncogene VL - 16 UR - https://doi.org/10.1038/sj.onc.1201932 DO - 10.1038/sj.onc.1201932 ID - Zhang1998 ER - TY - JOUR AU - Ouchi, T. AU - Monteiro, A. N. AU - August, A. AU - Aaronson, S. A. AU - Hanafusa, H. PY - 1998 DA - 1998// TI - BRCA1 regulates p53-dependent gene expression. JO - Proc Natl Acad Sci USA VL - 95 UR - https://doi.org/10.1073/pnas.95.5.2302 DO - 10.1073/pnas.95.5.2302 ID - Ouchi1998 ER - TY - JOUR AU - Chai, Y. L. AU - Cui, J. AU - Shao, N. PY - 1999 DA - 1999// TI - The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter. JO - Oncogene VL - 18 UR - https://doi.org/10.1038/sj.onc.1202323 DO - 10.1038/sj.onc.1202323 ID - Chai1999 ER - TY - JOUR AU - Harkin, D. P. AU - Bean, J. M. AU - Miklos, D. PY - 1999 DA - 1999// TI - Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. JO - Cell VL - 97 UR - https://doi.org/10.1016/S0092-8674(00)80769-2 DO - 10.1016/S0092-8674(00)80769-2 ID - Harkin1999 ER - TY - JOUR AU - Wang, Q. AU - Zhang, H. AU - Kajino, K. AU - Greene, M. I. PY - 1998 DA - 1998// TI - BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells. JO - Oncogene VL - 17 UR - https://doi.org/10.1038/sj.onc.1202403 DO - 10.1038/sj.onc.1202403 ID - Wang1998 ER - TY - JOUR AU - Fan, S. AU - Wang, J. AU - Yuan, R. PY - 1999 DA - 1999// TI - BRCA1 inhibition of estrogen receptor signaling in transfected cells. JO - Science VL - 284 UR - https://doi.org/10.1126/science.284.5418.1354 DO - 10.1126/science.284.5418.1354 ID - Fan1999 ER - TY - JOUR AU - Yu, X. AU - Wu, L. C. AU - Bowcock, A. M. AU - Aronheim, A. AU - Baer, R. PY - 1998 DA - 1998// TI - The C-terminal (BRCT) domains of BRCA1 interact in vivowith CtIP, a protein implicated in the CtBP pathway of transcriptional repression. JO - J Biol Chem VL - 273 UR - https://doi.org/10.1074/jbc.273.39.25388 DO - 10.1074/jbc.273.39.25388 ID - Yu1998 ER - TY - JOUR AU - Li, S. AU - Chen, P. L. AU - Subramanian, T. PY - 1999 DA - 1999// TI - Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. JO - J Biol Chem VL - 274 UR - https://doi.org/10.1074/jbc.274.16.11334 DO - 10.1074/jbc.274.16.11334 ID - Li1999 ER - TY - JOUR AU - Yarden, R. I. AU - Brody, L. C. PY - 1999 DA - 1999// TI - BRCA1 interacts with components of the histone deacetylase complex. JO - Proc Natl Acad Sci USA VL - 96 UR - https://doi.org/10.1073/pnas.96.9.4983 DO - 10.1073/pnas.96.9.4983 ID - Yarden1999 ER - TY - JOUR AU - Hakem, R. AU - de la Pompa, J. L. AU - Sirard, C. PY - 1996 DA - 1996// TI - The tumor suppressorgene Brca1is required for embryonic cellular proliferation in the mouse. JO - Cell VL - 85 UR - https://doi.org/10.1016/S0092-8674(00)81302-1 DO - 10.1016/S0092-8674(00)81302-1 ID - Hakem1996 ER - TY - JOUR AU - Milner, J. AU - Ponder, B. AU - Hughes-Davies, L. AU - Seltmann, M. AU - Kouzarides, T. PY - 1997 DA - 1997// TI - Transcriptional activation functions in BRCA2. JO - Nature VL - 386 UR - https://doi.org/10.1038/386772a0 DO - 10.1038/386772a0 ID - Milner1997 ER - TY - JOUR AU - Siddique, H. AU - Zou, J. P. AU - Rao, V. N. AU - Reddy, E. S. PY - 1998 DA - 1998// TI - The BRCA2 is a histoneacetyltransferase. JO - Oncogene VL - 16 UR - https://doi.org/10.1038/sj.onc.1202003 DO - 10.1038/sj.onc.1202003 ID - Siddique1998 ER - TY - JOUR AU - Fuks, F. AU - Milner, J. AU - Kouzarides, T. PY - 1998 DA - 1998// TI - BRCA2 associates with acetyltransferase activity when bound to P/CAF. JO - Oncogene VL - 17 UR - https://doi.org/10.1038/sj.onc.1202475 DO - 10.1038/sj.onc.1202475 ID - Fuks1998 ER - TY - JOUR AU - Robson, M. AU - Rajan, P. AU - Rosen, P. P. PY - 1998 DA - 1998// TI - BRCA-associated breast cancer: absence of a characteristic immunophenotype. JO - Cancer Res VL - 58 ID - Robson1998 ER - TY - JOUR AU - Osin, P. AU - Crook, T. AU - Powles, T. AU - Peto, J. AU - Gusterson, B. PY - 1998 DA - 1998// TI - Hormone status of in-situ cancer in BRCA1 and BRCA2mutation carriers. JO - Lancet VL - 351 UR - https://doi.org/10.1016/S0140-6736(98)24020-7 DO - 10.1016/S0140-6736(98)24020-7 ID - Osin1998 ER - TY - JOUR AU - Sharan, S. K. AU - Morimatsu, M. AU - Albrecht, U. PY - 1997 DA - 1997// TI - Embryonic lethality andradiation hypersensitivity mediated by Rad51 in mice lacking Brca2. JO - Nature VL - 386 UR - https://doi.org/10.1038/386804a0 DO - 10.1038/386804a0 ID - Sharan1997 ER - TY - JOUR AU - Shen, S. X. AU - Weaver, Z. AU - Xu, X. PY - 1998 DA - 1998// TI - A targeted disruption of the murine Brca1gene causes gamma-irradiation hypersensitivity and genetic instability. JO - Oncogene VL - 17 UR - https://doi.org/10.1038/sj.onc.1202243 DO - 10.1038/sj.onc.1202243 ID - Shen1998 ER - TY - JOUR AU - Connor, F. AU - Bertwistle, D. AU - Mee, P. J. PY - 1997 DA - 1997// TI - Tumorigenesis and a DNA repair defect in mice with a truncating Brca2mutation. JO - Nature Genet VL - 17 UR - https://doi.org/10.1038/ng1297-423 DO - 10.1038/ng1297-423 ID - Connor1997 ER - TY - JOUR AU - Patel, K. J. AU - Vu, V. P. AU - Lee, H. PY - 1998 DA - 1998// TI - Involvement of Brca2 in DNA repair. JO - Mol Cell VL - 1 UR - https://doi.org/10.1016/S1097-2765(00)80035-0 DO - 10.1016/S1097-2765(00)80035-0 ID - Patel1998 ER - TY - JOUR AU - Takata, M. AU - Sasaki, M. S. AU - Sonoda, E. PY - 1998 DA - 1998// TI - Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. JO - EMBO J VL - 17 UR - https://doi.org/10.1093/emboj/17.18.5497 DO - 10.1093/emboj/17.18.5497 ID - Takata1998 ER - TY - JOUR AU - Chen, Y. AU - Farmer, A. A. AU - Chen, C. F. PY - 1996 DA - 1996// TI - BRCA1 is a 220-kDa nuclearphosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. JO - Cancer Res VL - 56 ID - Chen1996 ER - TY - JOUR AU - Bertwistle, D. AU - Swift, S. AU - Marston, N. J. PY - 1997 DA - 1997// TI - Nuclear location and cell cycle regulation of the BRCA2 protein. JO - Cancer Res VL - 57 ID - Bertwistle1997 ER - TY - JOUR AU - Liang, F. AU - Han, M. AU - Romanienko, P. J. AU - Jasin, M. PY - 1998 DA - 1998// TI - Homology-directed repair is a major double-strand break repair pathway in mammalian cells. JO - Proc Natl Acad Sci USA VL - 95 UR - https://doi.org/10.1073/pnas.95.9.5172 DO - 10.1073/pnas.95.9.5172 ID - Liang1998 ER - TY - JOUR AU - Baumann, P. AU - West, S. C. PY - 1998 DA - 1998// TI - Role of the human Rad51 protein in homologous recombination and double-strand break repair. JO - Trends Biochem Sci VL - 23 UR - https://doi.org/10.1016/S0968-0004(98)01232-8 DO - 10.1016/S0968-0004(98)01232-8 ID - Baumann1998 ER - TY - JOUR AU - Scully, R. AU - Chen, J. AU - Plug, A. PY - 1997 DA - 1997// TI - Association of BRCA1 with Rad51 in mitotic and meiotic cells. JO - Cell VL - 88 UR - https://doi.org/10.1016/S0092-8674(00)81847-4 DO - 10.1016/S0092-8674(00)81847-4 ID - Scully1997 ER - TY - JOUR AU - Zhong, Q. AU - Chen, C. F. AU - Li, S. PY - 1999 DA - 1999// TI - Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. JO - Science VL - 285 UR - https://doi.org/10.1126/science.285.5428.747 DO - 10.1126/science.285.5428.747 ID - Zhong1999 ER - TY - JOUR AU - Gowen, L. C. AU - Avrutskaya, A. V. AU - Latour, A. M. AU - Koller, B. H. AU - Leadon, S. A. PY - 1998 DA - 1998// TI - BRCA1 required for transcription-coupled repair of oxidative DNA damage. JO - Science VL - 281 UR - https://doi.org/10.1126/science.281.5379.1009 DO - 10.1126/science.281.5379.1009 ID - Gowen1998 ER - TY - JOUR AU - Sonoda, E. AU - Sasaki, M. S. AU - Buerstedde, J. M. PY - 1998 DA - 1998// TI - Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. JO - EMBO J VL - 17 UR - https://doi.org/10.1093/emboj/17.2.598 DO - 10.1093/emboj/17.2.598 ID - Sonoda1998 ER - TY - JOUR AU - Michel, B. AU - Ehrlich, S. D. AU - Uzest, M. PY - 1997 DA - 1997// TI - DNA double-strand breaks caused by replication arrest. JO - EMBO J VL - 16 UR - https://doi.org/10.1093/emboj/16.2.430 DO - 10.1093/emboj/16.2.430 ID - Michel1997 ER - TY - JOUR AU - Zou, H. AU - Rothstein, R. PY - 1997 DA - 1997// TI - Holliday junctions accumulate in replication mutants via a RecA homolog-independent mechanism. JO - Cell VL - 90 UR - https://doi.org/10.1016/S0092-8674(00)80316-5 DO - 10.1016/S0092-8674(00)80316-5 ID - Zou1997 ER - TY - JOUR AU - Lim, D. S. AU - Hasty, P. PY - 1996 DA - 1996// TI - A mutation in mouse Rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. JO - Mol Cell Biol VL - 16 UR - https://doi.org/10.1128/MCB.16.12.7133 DO - 10.1128/MCB.16.12.7133 ID - Lim1996 ER - TY - JOUR AU - Lee, H. AU - Trainer, A. H. AU - Friedman, L. S. PY - 1999 DA - 1999// TI - Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2. JO - Mol Cell VL - 4 UR - https://doi.org/10.1016/S1097-2765(00)80182-3 DO - 10.1016/S1097-2765(00)80182-3 ID - Lee1999 ER - TY - JOUR AU - Ludwig, T. AU - Chapman, D. L. AU - Papaioannou, V. E. AU - Efstratiadis, A. PY - 1997 DA - 1997// TI - Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53 and Brca2/p53nullizygous embryos. JO - Genes Dev VL - 11 UR - https://doi.org/10.1101/gad.11.10.1226 DO - 10.1101/gad.11.10.1226 ID - Ludwig1997 ER - TY - JOUR AU - Crook, T. AU - Crossland, S. AU - Crompton, M. R. AU - Osin, P. AU - Gusterson, B. A. PY - 1997 DA - 1997// TI - p53 mutations in BRCA1-associated familial breast cancer. JO - Lancet VL - 350 UR - https://doi.org/10.1016/S0140-6736(05)63327-2 DO - 10.1016/S0140-6736(05)63327-2 ID - Crook1997 ER - TY - JOUR AU - Crook, T. AU - Brooks, L. A. AU - Crossland, S. PY - 1998 DA - 1998// TI - p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours. JO - Oncogene VL - 17 UR - https://doi.org/10.1038/sj.onc.1202106 DO - 10.1038/sj.onc.1202106 ID - Crook1998 ER - TY - JOUR AU - Xu, X. AU - Weaver, Z. AU - Linke, S. P. PY - 1999 DA - 1999// TI - Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1exon 11 isoform-deficient cells. JO - Mol Cell VL - 3 UR - https://doi.org/10.1016/S1097-2765(00)80466-9 DO - 10.1016/S1097-2765(00)80466-9 ID - Xu1999 ER - TY - JOUR AU - Larson, J. S. AU - Tonkinson, J. L. AU - Lai, M. T. PY - 1997 DA - 1997// TI - A BRCA1mutant alters G2-M cell cycle control in human mammary epithelial cells. JO - Cancer Res VL - 57 ID - Larson1997 ER - TY - JOUR AU - Hardwick, K. G. PY - 1998 DA - 1998// TI - The spindle checkpoint. JO - Trends Genet VL - 14 UR - https://doi.org/10.1016/S0168-9525(97)01340-1 DO - 10.1016/S0168-9525(97)01340-1 ID - Hardwick1998 ER - TY - JOUR AU - Zimmerman, W. AU - Sparks, C. A. AU - Doxsey, S. J. PY - 1999 DA - 1999// TI - Amorphous no longer: the centrosome comes into focus. JO - Curr Opin Cell Biol VL - 11 UR - https://doi.org/10.1016/S0955-0674(99)80015-5 DO - 10.1016/S0955-0674(99)80015-5 ID - Zimmerman1999 ER - TY - JOUR AU - Tutt, A. AU - Gabriel, A. AU - Bertwistle, D. PY - 1999 DA - 1999// TI - Absence of BRCA2causes genome instability by chromosome breakage and loss associated with centrosome amplification. JO - Curr Biol VL - 9 UR - https://doi.org/10.1016/S0960-9822(99)80479-5 DO - 10.1016/S0960-9822(99)80479-5 ID - Tutt1999 ER - TY - JOUR AU - Sluder, G. AU - Thompson, E. A. AU - Miller, F. J. AU - Hayes, J. AU - Rieder, C. L. PY - 1997 DA - 1997// TI - The checkpoint control for anaphase onset does not monitor excess numbers of spindle poles or bipolar spindle symmetry. JO - J Cell Sci VL - 110 ID - Sluder1997 ER - TY - JOUR AU - Doxsey, S. PY - 1998 DA - 1998// TI - The centrosome: a tiny organelle with big potential. JO - Nature Genet VL - 20 UR - https://doi.org/10.1038/2392 DO - 10.1038/2392 ID - Doxsey1998 ER - TY - JOUR AU - Hsu, L. C. AU - White, R. L. PY - 1998 DA - 1998// TI - BRCA1 is associated with the centrosome during mitosis. JO - Proc Natl Acad Sci USA VL - 95 UR - https://doi.org/10.1073/pnas.95.22.12983 DO - 10.1073/pnas.95.22.12983 ID - Hsu1998 ER - TY - JOUR AU - Hinchcliffe, E. H. AU - Li, C. AU - Thompson, E. A. AU - Maller, J. L. AU - Sluder, G. PY - 1999 DA - 1999// TI - Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopusegg extracts. JO - Science VL - 283 UR - https://doi.org/10.1126/science.283.5403.851 DO - 10.1126/science.283.5403.851 ID - Hinchcliffe1999 ER - TY - JOUR AU - Tirkkonen, M. AU - Johannsson, O. AU - Agnarsson, B. A. PY - 1997 DA - 1997// TI - Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2germ-line mutations. JO - Cancer Res VL - 57 ID - Tirkkonen1997 ER - TY - JOUR AU - Holt, J. T. PY - 1997 DA - 1997// TI - Breast cancer genes: therapeutic strategies. JO - Ann N Y Acad Sci VL - 833 UR - https://doi.org/10.1111/j.1749-6632.1997.tb48590.x DO - 10.1111/j.1749-6632.1997.tb48590.x ID - Holt1997 ER -